Skip to main content
SpringerLink
Log in

Hepatitis C and Lymphoma

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Epidemiologic and experimental data are presented that suggest the involvement of the hepatitis C virus in the pathogenesis of some histotypes of B-cell non-Hodgkin’s lymphoma, in particular immunocytoma, marginal zone lymphoma, and diffuse large cell lymphoma. Clinical presentation, including association with cryoglobulinemic syndrome, is described and therapeutic options are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490–1495.

    Article  PubMed  CAS  Google Scholar 

  2. Monteverde A, Sabattini E, Poggi S, et al.: Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995, 20:119–124.

    Article  PubMed  CAS  Google Scholar 

  3. Franzin F, Efremov DG, Pozzato G, et al.: Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995, 90:548–552.

    Article  PubMed  CAS  Google Scholar 

  4. Ferri C, Monti M, La Civita L, et al.: Hepatitis C virus infection in non-Hodgkin’s B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994, 24:781–784.

    Article  PubMed  CAS  Google Scholar 

  5. Pozzato G, Mazzaro C, Crovatto M, et al.: Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994, 84:3047–3053.

    PubMed  CAS  Google Scholar 

  6. Di Stasi M, Sbolli G, Fornari F, et al.: Hepatocellular carcinoma and B-cell tumor. J Hepatol 1994, 21:1146–1147.

    Article  PubMed  Google Scholar 

  7. Ferri C, Caracciolo F, Zignego AL, et al.: Hepatitis C virus infection in patients with non-Hodgkin’s lymphoma. Br J Haematol 1994, 88:392–394.

    Article  PubMed  CAS  Google Scholar 

  8. Silvestri F, Pipan C, Barillari G, et al.: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996, 87:4296–4301.

    PubMed  CAS  Google Scholar 

  9. Silvestri F, Barillari G, Fanin R, et al.: Risk of hepatitis C virus infection, Waldenström’s macroglobulinemia, and monoclonal gammopathies. Blood 1996, 88:1125–1126.

    PubMed  CAS  Google Scholar 

  10. Silvestri F, Baccarani M: Hepatitis C virus-related lymphoma. Br J Haematol 1997, 99:475–480.

    Article  PubMed  CAS  Google Scholar 

  11. Domingo JM, Romero S, Moreno JA, et al.: Hepatitis C virus infection and mixed cryoglobulinemia in patients with lymphoproliferative diseases. Haematologica 1999, 84:94–96.

    PubMed  CAS  Google Scholar 

  12. Shirin H, Davidovitz Y, Avni Y, et al.: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc 2002, 4:24–27.

    Google Scholar 

  13. Chindamo MC, Spector N, Segadas JA, et al.: Prevalence of hepatitis C infection in patients with non-Hodgkin’s lymphomas. Oncol Rep 2002, 9:657–659.

    PubMed  Google Scholar 

  14. Pulsoni A, Bianco E, Szklo A, et al.: Hepatitis C virus (HCV) and lymphopoliferative disorders: a multicentre case-control study. Ann Oncol 2002, 13(suppl 2):21.

    Google Scholar 

  15. Ellenrieder V, Weidenbach H, Frickhofen N, et al.: HCV and HGV in B-cell non-Hodgkin’s lymphoma. J Hepatol 1998, 28:34–39.

    Article  PubMed  CAS  Google Scholar 

  16. Germanidis G, Haioun C, Pourquier J, et al.: Hepatitis C virus infection in patients with overt B-cell non-Hodgkin’s lymphoma in a French center. Blood 1999, 93:1778–1779.

    PubMed  CAS  Google Scholar 

  17. King PD, Wilkes JD, Diaz-Arias AA: Hepatitis C virus infection in non-Hodgkin’s lymphoma. Clin Lab Haematol 1998, 20:107–110.

    Article  PubMed  CAS  Google Scholar 

  18. Hausfater P, Cacoub P, Sterkers Y, et al.: Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001, 67:168–171.

    Article  PubMed  CAS  Google Scholar 

  19. Rabkin CS, Tess BH, Christianson RE, et al.: Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002, 99:4240–4242.

    Article  PubMed  CAS  Google Scholar 

  20. Silvestri F, Barillari G, Fanin R, et al.: Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin’s lymphomas. Haematologica 1997, 82:314–317.

    PubMed  CAS  Google Scholar 

  21. Silvestri F, Barillari G, Fanin R, et al.: Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmocytoid lymphoma/ immunocytoma. Ann Oncol 1998, 9:1–6.

    Article  Google Scholar 

  22. Ivanovski M, Silvestri F, Pozzato G, et al.: Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998, 91:2433–2442.

    PubMed  CAS  Google Scholar 

  23. Pioltelli P, Zehender G, Monti G, et al.: HCV and non-Hodgkin lymphoma. Lancet 1996, 347:624–625.

    Article  PubMed  CAS  Google Scholar 

  24. Luppi M, Longo G, Ferrari MG, et al.: Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996, 94:373–375.

    Article  PubMed  CAS  Google Scholar 

  25. Tkoub EM, Haioun C, Pawlotsky JM, et al.: Chronic hepatitis C virus and gastric MALT lymphoma. Blood 1998, 91:360–369.

    PubMed  CAS  Google Scholar 

  26. Silvestri F, Barillari G, Fanin R, et al.: Hepatitis C virus infection (and additional neoplasm) among marginal zone lymphomas. Br J Haematol 1997, 96:427–428.

    Article  PubMed  CAS  Google Scholar 

  27. De Vita S, Sacco C, Sansonno D, et al.: Characterization of overt B-cell lymphoma in patients with hepatitis C virus infection. Blood 1997, 90:776–782.

    PubMed  Google Scholar 

  28. Page RD, Romaguera J, Osborne B, et al.: Primary hepatic lymphoma and association of hepatitis C viral infection. Blood 1996, 88(suppl 1):223a.

    Google Scholar 

  29. Izumi T, Sasaki R, Miura Y, et al.: Primary hepatosplenic lymphoma: association with hepatitis C virus infection. Blood 1996, 87:5380–5381.

    PubMed  CAS  Google Scholar 

  30. Rubbia-Brandt L, Brundler MA, Kerl K, et al.: Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis C. Am J Surg Pathol 1999, 23:1124–1230.

    Article  PubMed  CAS  Google Scholar 

  31. De Vita S, Zagonel V, Russo A, et al.: Hepatitis C virus, non-Hodgkin’s lymphomas and hepatocellular carcinoma. Br J Cancer 1998, 77:2032–2035.

    PubMed  Google Scholar 

  32. Prati D, Zanella A, De Mattei C, et al.: Chronic hepatitis C virus infection and primary cutaneous B-cell lymphoma. Br J Haematol 1999, 105:839–850.

    Article  Google Scholar 

  33. McKiernan S, Pilkinton R, Ramsay B, et al.: Primary cutaneous B-cell lymphoma: an association of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999, 11:669–672.

    Article  PubMed  CAS  Google Scholar 

  34. De Re V, De Vita S, Marzotto A, et al.: Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000, 96:3578–3584. The findings suggest that the malignant proliferation is derived from an antigen-driven pathologic process, with a common antigen (HCV) involved in MC syndrome and in HCV-associated NHL.

    PubMed  Google Scholar 

  35. Hubert Chan C, Hadlock KG, Foung SKH, et al.: VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001, 97:1023–1026.

    Article  Google Scholar 

  36. Quinn ER, Hubert Chan C, Hadlock KG, et al.: The B-cell receptor of hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001, 98:3745–3749. The findings of these two papers (references 35 and 36) support the hypothesis that the driving antigen involved in the clonal expansion of the B-cell is HCV, in particular the HCV-E2 protein.

    Article  PubMed  CAS  Google Scholar 

  37. Mazzaro C, Franzin F, Tulissi P, et al.: Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996, 77:2604–2613.

    Article  PubMed  CAS  Google Scholar 

  38. Patriarca F, Silvestri F, Fanin R, et al.: Long-lasting complete remission of hepatitis C virus (HCV) infection and HCVassociated immunocytoma with alpha-interferon treatment. Br J Haematol 2001, 112:370–372. Clearance of the virus under IFN treatment allowed complete remission of a case of immunocytoma in partial remission after fludarabine.

    Article  PubMed  CAS  Google Scholar 

  39. Zuckerman E, Zuckerman T, Douer D, et al.: Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998, 83:1224–1230.

    Article  PubMed  CAS  Google Scholar 

  40. Silvestri F, Barillari G, Fanin R, et al.: Hepatic toxicity of chemotherapy among hepatitis C virus (HCV)-associated non-Hodgkin’s lymphomas (NHL). Blood 1998, 92(suppl 1):230b.

    Google Scholar 

  41. Vallisa D, Berte R, Rocca A, et al.: Association between hepatitis C virus and non-Hodgkin’s lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999, 106:556–560.

    Article  PubMed  CAS  Google Scholar 

  42. Sperotto A, Silvestri F, Fanin R, et al.: Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-haematological diseases. Haematologica 1999, 84:1052–1053.

    Google Scholar 

  43. Silvestri F, Barillari G, Fanin R, et al.: The genotype of the hepatitis C virus in patients with HCV-related B-cell non-Hodgkin’s lymphoma. Leukemia 1997, 11:2157–2161.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, University Hospital, 33100, Udine, Italy

    Federico Silvestri MD, Alessandra Sperotto MD & Renato Fanin MD

Authors
  1. Federico Silvestri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandra Sperotto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato Fanin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silvestri, F., Sperotto, A. & Fanin, R. Hepatitis C and Lymphoma. Current Hepatitis Reports 1, 5–8 (2002). https://doi.org/10.1007/s11901-002-0002-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-002-0002-x

Keywords

Search

Navigation